Similar articles

• Long-term mortality after screening for colorectal cancer.

  Shaukat A, Mongin SJ, Geisser MS, Lederle FA, Bond JH, Mandel JS, Church TR. Shaukat A, et al. N Engl J Med. 2013 Sep 19;369(12):1106-14. doi: 10.1056/NEJMoa1300720. N Engl J Med. 2013. PMID: 24047060 Clinical Trial.
• Early detection of colorectal cancer with faecal occult blood test screening.

  Paimela H, Malila N, Palva T, Hakulinen T, Vertio H, Järvinen H. Paimela H, et al. Br J Surg. 2010 Oct;97(10):1567-71. doi: 10.1002/bjs.7150. Br J Surg. 2010. PMID: 20603855 Clinical Trial.
• Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing.

  Wong CK, Lam CL, Wan YF, Fong DY. Wong CK, et al. BMC Cancer. 2015 Oct 15;15:705. doi: 10.1186/s12885-015-1730-y. BMC Cancer. 2015. PMID: 26471036 Free PMC article. Clinical Trial.
• [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].

  Quintero E. Quintero E. Gastroenterol Hepatol. 2009 Oct;32(8):565-76. doi: 10.1016/j.gastrohep.2009.01.179. Epub 2009 Jul 3. Gastroenterol Hepatol. 2009. PMID: 19577340 Review. Spanish.
• [Features of colorectal cancer with fecal-occult-blood tests--comparison with colorectal cancer with no screening].

  Takemasa I, Kikkawa N, Yasui M, Nishisho I, Fujitani K, Mishima H, Hasuike Y, Kobayashi K. Takemasa I, et al. Gan To Kagaku Ryoho. 1998 Aug;25(10):1514-8. Gan To Kagaku Ryoho. 1998. PMID: 9725042 Review. Japanese.